Notice of Effectiveness (effect)
22 Mars 2018 - 11:01AM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
March 21,
2018
|
|
Accession Number:
|
0001193125-18-076357
|
|
Submission Type:
|
POS AM
|
|
CIK:
|
0001412067
|
|
Company Name:
|
Cascadian Therapeutics, Inc.
|
|
File Number:
|
333-217773
|
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
Real-Time news about Cascadian Therapeutics, Inc. (delisted) (NASDAQ): 0 recent articles
Plus d'articles sur Cascadian Therapeutics, Inc.